On the other hand, cell viability of GBM cells were increased when AKT phosphorylation was induced by SC79 treatment, however, GJ/CDDP co-treatment competitively reduced the SC79-induced cell viability (Figure 6g) by inhibiting p-AKT expression (Figure 6f). The gene discussed is AKT1; the disease is glioblastoma.